Literature DB >> 25542051

Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis.

José Ramón Paño Pardo1, Sergio Serrano Villar2, Juan Carlos Ramos Ramos1, Vicente Pintado2.   

Abstract

Infections caused by carbapenem-producing Enterobacteriaceae (CPE) can present as several infectious syndromes, but they primarily present as respiratory, urinary and blood stream infections (primary or catheter-related) that are usually found as nosocomial or healthcare-associated infections. The risk of CPE infection is influenced by individual factors, such as the length of the hospital stay and their exposure to invasive procedures and/or to antimicrobials. Of note, exposure to several antimicrobials, not only carbapenems, has been linked to CPE colonization; the duration of antibiotic exposure is one of the primary drivers of CPE acquisition. Individual risk factors must be considered jointly with the local epidemiology of these microorganisms in healthcare institutions. Overall, these infections have a high associated mortality. Mortality is influenced by host factors (e.g., age, comorbidity and immune deficiency), infection-related variables (e.g., type and severity of the infection) and treatment-related factors such as the delay in the initiation of appropriate antimicrobial therapy and the use or monotherapy or combined antimicrobial therapy. Gaining knowledge concerning the epidemiology, clinical features and prognostic features of CPE infection could be useful for improving infection prevention and for the management of patients with infections caused by these microorganisms.
Copyright © 2014 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Bacteriemia; Bloodstream infections; Características clínicas; Carbapenemase-producing; Clinical features; Enterobacteriaceae; Enterobacterias productoras de carbapenemasas; Factores de riesgo; Factores pronósticos; Prognostic factors; Risk factors

Mesh:

Substances:

Year:  2014        PMID: 25542051     DOI: 10.1016/S0213-005X(14)70173-9

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  13 in total

1.  Successful Treatment of Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Bacteremia.

Authors:  Jose F Camargo; Jacques Simkins; Thiago Beduschi; Akin Tekin; Laura Aragon; Armando Pérez-Cardona; Clara E Prado; Michele I Morris; Lilian M Abbo; Rafael Cantón
Journal:  Antimicrob Agents Chemother       Date:  2015-10       Impact factor: 5.191

2.  A hospital-based matched case-control study to identify risk factors for clinical infection with OXA-48-producing Klebsiella pneumoniae in rectal carriers.

Authors:  A Madueño; J Gonzalez Garcia; A Aguirre-Jaime; M Lecuona
Journal:  Epidemiol Infect       Date:  2017-07-17       Impact factor: 4.434

3.  Community-Onset Bloodstream and Other Infections, Caused by Carbapenemase-Producing Enterobacteriaceae: Epidemiological, Microbiological, and Clinical Features.

Authors:  José Ramón Paño-Pardo; Beatriz López Quintana; Fernando Lázaro Perona; Guillermo Ruiz Carrascoso; María Pilar Romero-Gómez; Belén Loeches Yagüe; Beatriz Díaz-Pollán; Ana Martínez-Virto; Jesús Mingorance; Julio García Rodríguez; José Ramón Arribas; Rosa Gómez-Gil
Journal:  Open Forum Infect Dis       Date:  2016-08-01       Impact factor: 3.835

Review 4.  Screening for carriage of carbapenem-resistant Enterobacteriaceae in settings of high endemicity: a position paper from an Italian working group on CRE infections.

Authors:  Simone Ambretti; Matteo Bassetti; Pierangelo Clerici; Nicola Petrosillo; Fabio Tumietto; Pierluigi Viale; Gian Maria Rossolini
Journal:  Antimicrob Resist Infect Control       Date:  2019-08-13       Impact factor: 4.887

5.  Intestinal co-colonization with different carbapenemase-producing Enterobacterales isolates is not a rare event in an OXA-48 endemic area.

Authors:  Marta Hernández-García; Blanca Pérez-Viso; Carolina Navarro-San Francisco; Fernando Baquero; María Isabel Morosini; Patricia Ruiz-Garbajosa; Rafael Cantón
Journal:  EClinicalMedicine       Date:  2019-10-17

6.  Factors associated with acquisition of carbapenem-resistant Enterobacteriaceae.

Authors:  Lilian Silva Lavagnoli; Bil Randerson Bassetti; Thais Dias Lemos Kaiser; Kátia Maria Kutz; Crispim Cerutti
Journal:  Rev Lat Am Enfermagem       Date:  2017-10-05

7.  Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution.

Authors:  Ximena Gonzalo; Giovanni Satta; Julio Ortiz Canseco; Timothy D McHugh; Francis Drobniewski
Journal:  BMC Microbiol       Date:  2020-08-31       Impact factor: 3.605

8.  [Risk factors and clinical evolution of carbapenemase-producing Klebsiella pneumoniae infections in a university hospital in Spain. Case-control study].

Authors:  V Rojo; P Vázquez; S Reyes; L Puente Fuertes; M Cervero
Journal:  Rev Esp Quimioter       Date:  2018-09-18       Impact factor: 1.553

9.  [Epidemiology and clinical of infections and colonizations caused by Enterobacterales producing carbapenemases in a tertiary hospital].

Authors:  I Pintos-Pascual; M Cantero-Caballero; E Muñez Rubio; I Sánchez-Romero; A Asensio-Vegas; A Ramos-Martínez
Journal:  Rev Esp Quimioter       Date:  2020-03-09       Impact factor: 1.553

10.  Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.

Authors:  Li Yan; Jide Sun; Xiuyu Xu; Shifeng Huang
Journal:  Antimicrob Resist Infect Control       Date:  2020-09-23       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.